Brief: Carsgen Therapeutics Says It Has Been Selected As An Eligible Stock In Respective Stock Lists Of Shanghai-Hong Kong Stock Connect Programme
07/03/2022 01:32
March 7 (Reuters) - CARsgen Therapeutics Holdings Ltd
2171.HK :
* HAS BEEN SELECTED AND INCLUDED AS AN ELIGIBLE STOCK IN
RESPECTIVE STOCK LISTS OF SHANGHAI-HONG KONG STOCK CONNECT
PROGRAMME
Source text for Eikon: ID:nHKSbc2XNk
Further company coverage: 2171.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CARsgen Therapeutics Holdings
See all newsBrief: Carsgen Therapeutics Says CT1190B Receives IND Clearance From NMPA For Relapsed/Refractory Large B-Cell Lymphoma
Brief: Carsgen Therapeutics Says CT0596 Receives IND Clearance From NMPA
Brief: Carsgen Therapeutics Approves Share Repurchase Plan For Up To 30.12 Million Shares
CARsgen Therapeutics climbs on board nod for share buyback
Brief: Carsgen Therapeutics Says NMPA Approves Satricabtagene Autoleucel For Advanced Gastric Cancer